CAlgary SAlt for Postural Orthostatic Tachycardia Syndrome (CASA-POTS)
Summary
This study will evaluate high-salt compared to moderate-salt over a period of about 3 months. The purpose of this study is to see if increasing the amount of salt in the diet will reduce heart rate and symptoms in patients with POTS when compared to placebo (cellulose pill). To do this, we are conducting a randomized-clinical trial looking at a high-salt diet compared to a moderate-salt diet. This is a cross-over study, meaning that participants will do both the high-salt and moderate-salt components of the study. The study will have three in lab evaluations as well as online surveys.
Eligibility
Eligible ages: 18 to 60
Inclusion criteria:
-Physician Diagnosis of POTS
-Age 18-60 years old.
-Ability to attend the Calgary Autonomic Research Lab Clinic in Calgary
-Resident of Canada
Exclusion criteria:
-Participants who do not have a physician diagnosis of POTS
-Participants who are pregnant
-Participants who are taking fludrocortisone (Florinef)
-Participants who have received IV saline in the 2 months preceding the study or who plan to receive it during the course of the study
Participate
Additional information
Contact information
autonomic.research@ucalgary.ca
Principal investigator:
Satish Raj
Clinical trial:
Yes
REB-ID:
REB23-0779